700-36-7

Basic information

• Product Name: 2-Bromo-4-fluoronitrobenzene
• Synonyms: 2-bromo-4-fluoro-1-nitrobenzene;1-Bromo-5-fluoro-2-nitrobenzene;2-Bromo-4-fluoronitrobenzene;2-BroMo-4-fluoronitrobenzene, 97+%
• CAS NO: 700-36-7
• Molecular Formula: C₆H₃BrFNO₂
• Molecular Weight: 220
• EINECS: 1533716-785-6
• Mol File: 700-36-7.mol
• Article Data: 10

Chemical Properties

• Melting Point: 44 °C
• Boiling Point: 224 °C at 760 mmHg
• Flash Point: 89.3 °C
• Appearance: Pale yellow to green/Solid
• Density: 1.808 g/cm³
• Vapor Pressure: 0.139mmHg at 25°C
• Refractive Index: 1.579
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: soluble in Methanol
• CAS DataBase Reference: 2-Bromo-4-fluoronitrobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Bromo-4-fluoronitrobenzene(700-36-7)
• EPA Substance Registry System: 2-Bromo-4-fluoronitrobenzene(700-36-7)

Safety Data

• Safety Statements: 24/25
• Hazardous Substances Data: 700-36-7(Hazardous Substances Data)

Usage

Chemical Properties

Yellow to pale green powder

InChI:InChI=1/C6H3BrFNO2/c7-5-3-4(8)1-2-6(5)9(10)11/h1-3H

Upstream product

• 1003-98-1 2-bromo-4-fluoroaniline 
• 320-98-9 5-fluoro-2-nitrobenzoic acid 
• 540-80-7 tert.-butylnitrite 
• 369-36-8 6-fluoro-3-nitroaniline 
• 371-40-4 4-fluoroaniline 
• 1073-06-9 3-fluorobromobenzene 

Downstream Products

• 166818-85-5 1-(3-bromo-4-nitrophenyl)-4-methylpiperazine 
• 408355-23-7 7-bromo-5-fluoro-1H-indole 
• 875305-87-6 5-fluoroindole-7-carboxylic acid 
• 908600-70-4 5-fluoroindole-4-carboxylic acid 
• 908600-86-2 5-fluoro-1-(triisopropylsilyl)-1H-indole 
• 399-52-0 5-fluoro-1H-indole 
• 169674-02-6 4-chloro-5-fluoroindole 
• 1717-22-2 2-amino-5-fluorobiphenyl 
• 885692-98-8 1-(3-cyclohex-1-enyl-4-nitro-phenyl)-4-methyl-piperazine 
• 57279-69-3 2-bromo-4-ethoxy-1-nitro-benzene 
• 1185916-48-6 C₁₀H₆FNO₂S 
• 400-91-9 1-bromo-3-fluoro-4,6-dinitrobenzene 
• 594844-44-7 2-(3-bromo-4-nitrophenyl)malonic acid tert-butyl ester methyl ester 
• 943247-79-8 2-bromo-4-(2-methoxy-1-methylethoxy)-1-nitrobenzene 

Relevant articles and documents

Preparation method of 3-bromo-4-bromonitrophenol

The invention discloses an industrial preparation method of 3-bromo-4-bromonitrophenol. According to the industrial preparation method of the 3-bromo-4-bromonitrophenol, p-fluoroaniline serves as an initial raw material, and the 3-bromo-4-bromonitrophenol

Decarboxylative Halogenation and Cyanation of Electron-Deficient Aryl Carboxylic Acids via Cu Mediator as Well as Electron-Rich Ones through Pd Catalyst under Aerobic Conditions

Simple strategies for decarboxylative functionalizations of electron-deficient benzoic acids via using Cu(I) as promoter and electron-rich ones by employing Pd(II) as catalyst under aerobic conditions have been established, which lead to smooth synthesis of aryl halides (-I, Br, and Cl) through the decarboxylative functionalization of benzoic acids with readily available halogen sources CuX (X = I, Br, Cl), and easy preparation of benzonitriles from decarboxylative cyanation of aryl carboxylic acids with nontoxic and low-cost K4Fe(CN)6 under an oxygen atmosphere for the first time.

NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS

The present invention relates to the field of medicine, provided herein are novel nitrogenous heterocyclic compounds, their preparation methods and their uses as drugs, especially for treatment and prevention of tissue fibrosis. Also provided herein are pharmaceutically acceptable compositions comprising the nitrogenous heterocyclic compounds and the uses of the compositions in the treatment of human or animal tissue fibrosis, especially for human or animal renal interstitial fibrosis, glomerular sclerosis, liver fibrosis, pulmonary fibrosis, peritoneal fibrosis, myocardial fibrosis, dermatofibrosis, postsurgical adhesion, benign prostatic hyperplasia, skeletal muscle fibrosis, scleroderma, multiple sclerosis, pancreatic fibrosis, cirrhosis, myosarcoma, neurofibroma, pulmonary interstitial fibrosis, diabetic nephropathy, alzheimer disease or vascular fibrosis.